Epilepsy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing to sign and date a consent form agreeing to take part in the study
- People who are willing to follow all of the study's procedures throughout the trial
- People who have been diagnosed with post-traumatic epilepsy — meaning a neurologist has diagnosed them with epilepsy based on their clinical assessment or a brainwave test (EEG), they have a history of at least a mild traumatic brain injury (TBI), and the brain injury occurred before the epilepsy began
- People who are experiencing symptoms of anxiety or depression above a certain level, as measured by standard questionnaires used in the study (confirm with trial site for exact score thresholds)
- People who are already receiving neurological care at one of the participating study sites
Who may not be able to join:
- People who are already being actively treated by a psychiatrist in a way that the study investigators do not believe would benefit from the additional support this trial offers
- People who are currently having thoughts of suicide
- People who have previously attempted suicide
- People with current unstable drug or alcohol abuse problems
- People with an unstable or worsening medical condition alongside their epilepsy
- People who are currently taking part in another treatment or intervention research study
- People whose cognitive difficulties would prevent them from completing anxiety and depression questionnaires, whether on paper, electronically, or through an interview
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Heidi M. Munger Clary, MD, MPH, Atrium Health Wake Forest Baptist
Phone: 336-716-7110
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Emotional Subscale-Change in Quality of Life in Epilepsy-31(QOLIE-31)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.